Rollins Other Income (Expense) decreased by 77.8% to $463.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.1%, from $692.00K to $463.00K. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -54.3% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $891.00K | $447.00K | $2.08M | $1.28M | $1.91M | $1.98M | $3.00M | $4.71M | $1.02M | $493.00K | $15.86M | -$61.00K | $412.00K | $582.00K | $692.00K | $292.00K | $350.00K | $2.08M | $463.00K |
| QoQ Change | — | -49.8% | +365.5% | -38.5% | +49.4% | +3.6% | +51.4% | +57.3% | -78.4% | -51.6% | >999% | -100.4% | +775.4% | +41.3% | +18.9% | -57.8% | +19.9% | +494.9% | -77.8% |
| YoY Change | — | — | — | — | +114.5% | +343.0% | +44.0% | +268.6% | -46.7% | -75.1% | +429.2% | -101.3% | -59.6% | +18.1% | >999% | -29.1% | -39.9% | — | -33.1% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $692.00K | $292.00K | $350.00K | -$4.75M | $463.00K |
| Total | $692.00K | $292.00K | $350.00K | $2.08M | $463.00K |